News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

Sarepta Therapeutics Announces Positive Results from the SRP-9003 Gene Therapy Trial to Treat LGMD2E

By Sujatha Gurunathan | June 11, 2020
Blog Post

ReveraGen BioPharma Announces Completion of Vamorolone Study in 41 DMD Patients

By Sujatha Gurunathan | June 8, 2020
Featured Article

MDA’s 2020 Clinical Scientific Conference Trial News and Updates

By MDA Staff | May 15, 2020
Blog Post

Acceleron Pharma Announces Discontinuation of Clinical Trials Program for CMT

By Jeanene Swanson | March 18, 2020
Blog Post

NS Pharma Launches Expanded Access Program for Viltolarsen

By Jeanene Swanson | March 9, 2020
Illustration of DNA
Blog Post

FDA Accepts NS Pharma’s NDA for Viltolarsen for the Treatment of DMD Amenable to Exon 53 Skipping

By Jeanene Swanson | February 26, 2020
Blog Post

MDA’s New Chief Research Officer Sharon Hesterlee Shares Vision for the Future

By Jeanene Swanson | February 21, 2020
Blog Post

Clinical Trial Alert: Expansion Therapeutics Seeks Participants for a Phase 1 DM1 Study

By MDA Staff | February 18, 2020
Blog Post

Clinical Trial Alert: LGMD2I Participants Sought for a Phase 3 Study

By MDA Staff | February 11, 2020
Blog Post

Clinical Trial Alert: Mitsubishi Tanabe Pharma Seeks Participants for a Phase 3 ALS Study

By MDA Staff | February 5, 2020